This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Finding ways to use credit card points for experiences can enhance your lifestyle. Discover unique opportunities to enjoy your rewards.
23,332 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
As AI reshapes markets and policy, this analysis draws lessons from America's founding framework to guide personal fi...
As SpaceX prepares to debut on the public market, analysts clash over whether the company is fairly valued amid volat...
BNB Chain announces a sweeping overhaul aimed at 1,000,000 transactions per second, as its token slips to 2024-era lo...
Micron Technology’s shares sit around $938 after a dramatic year that saw the stock surge from roughly $124 to well o...
A rare public sighting of Madelaine Petsch and Tyga offers more than fashion chatter. It doubles as a practical look ...
A bitcoin whale from 2018 moved 2,931 BTC valued at roughly $188 million, signaling a rare on-chain awakening with no...
A new permanent-capital firm aims to acquire cash-flowing U.S. businesses from aging founders, paying part in stock a...
The Digital Chamber filed a lawsuit against Illinois over a 0.2% tax on digital asset transactions, arguing the levy ...
HF Sinclair delivered a solid earnings beat, but shares fell sharply after leadership news. This article breaks down ...
A prototype AI agent reportedly moved an entire Lobstar token stake to a social-media reply target, booked quick prof...
A high-profile PR moment becomes a money lesson. This article breaks down how apology politics affect fame and fortun...